Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

[1]  D. Muthu,et al.  Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure , 2009 .

[2]  N. S. Pollitt,et al.  The precursor to B-type natriuretic peptide is an O-linked glycoprotein. , 2006, Archives of biochemistry and biophysics.

[3]  C. Granier,et al.  Assay for measurement of intact B-type natriuretic peptide prohormone in blood. , 2006, Clinical chemistry.

[4]  H Robert Bergen,et al.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. J. Bold,et al.  Determinants of inducible brain natriuretic peptide promoter activity , 2005, Regulatory Peptides.

[6]  M. Yanagisawa,et al.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. , 2005, The Journal of clinical investigation.

[7]  A. Jaffe,et al.  Quality specifications for B-type natriuretic peptide assays. , 2005, Clinical chemistry.

[8]  J. Goetze.  Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. , 2004, Clinical chemistry.

[9]  R. Rodeheffer.  Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? , 2004, Journal of the American College of Cardiology.

[10]  M. Kuhn.  Molecular physiology of natriuretic peptide signalling , 2004, Basic Research in Cardiology.

[11]  K. Sugita,et al.  Characterization of molecular forms of probrain natriuretic peptide in human plasma. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Rehfeld,et al.  The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure? , 2003, European heart journal.

[13]  RudolfBerger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002 .

[14]  R. Hammer,et al.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Tamaki,et al.  Molecular forms of human brain natriuretic peptide in plasma. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[16]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[17]  A. Protter,et al.  Clearance of human brain natriuretic peptide in rabbits; effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity. , 1999, The Journal of pharmacology and experimental therapeutics.

[18]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .

[19]  M. Garami,et al.  Mechanical Strain Increases Expression of the Brain Natriuretic Peptide Gene in Rat Cardiac Myocytes* , 1997, Journal of Biological Chemistry.

[20]  A. Protter,et al.  Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. , 1996, American journal of hypertension.

[21]  K. Nakao,et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.

[22]  S Sasayama,et al.  Ventricular Expression of Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy , 1993, Circulation.

[23]  A. Richards,et al.  Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.

[24]  T. Ogihara,et al.  Concentrations and molecular forms of human brain natriuretic peptide in plasma. , 1992, Biochemical and biophysical research communications.

[25]  J. Lewicki,et al.  Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. , 1990, The Journal of biological chemistry.

[26]  H. Imura,et al.  Increased human brain natriuretic peptide in congestive heart failure. , 1990, The New England journal of medicine.

[27]  N. Minamino,et al.  Isolation and identification of human brain natriuretic peptides in cardiac atrium. , 1990, Biochemical and biophysical research communications.

[28]  J. Lewicki,et al.  Human and canine gene homologs of porcine brain natriuretic peptide. , 1989, Biochemical and biophysical research communications.

[29]  R. Fiscus,et al.  Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta , 1989, Neuropeptides.

[30]  N. Minamino,et al.  Isolation and identification of rat brain natriuretic peptides in cardiac atrium. , 1989, Biochemical and biophysical research communications.

[31]  J. Lewicki,et al.  Clearance function of type C receptors of atrial natriuretic factor in rats. , 1989, The American journal of physiology.